Aurobindo Pharma Limited (AUROPHARMA) — Working Capital to Net Assets Ratio
Aurobindo Pharma Limited (AUROPHARMA) has a Working Capital to Net Assets ratio of 37.5% as of September 2025. Working capital of Rs131.48 Billion (current assets of Rs286.49 Billion minus current liabilities of Rs155.01 Billion) is measured against net assets of Rs350.34 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See AUROPHARMA net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Aurobindo Pharma Limited Working Capital to Net Assets (2004–2025)
This chart shows how Aurobindo Pharma Limited's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of September 2025, the ratio stands at 37.5%, reflecting working capital of Rs131.48 Billion against net assets of Rs350.34 Billion INR. Check AUROPHARMA tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Aurobindo Pharma Limited (2004–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Aurobindo Pharma Limited from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Aurobindo Pharma Limited.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 38.2% | Rs124.80 Billion | Rs326.47 Billion | Rs271.62 Billion | Rs146.82 Billion | ▼ -2.0 pp |
| 2024 | 40.2% | Rs120.06 Billion | Rs298.51 Billion | Rs242.06 Billion | Rs121.99 Billion | ▲ +2.8 pp |
| 2023 | 37.4% | Rs100.52 Billion | Rs268.52 Billion | Rs215.46 Billion | Rs114.94 Billion | ▼ -3.1 pp |
| 2022 | 40.6% | Rs99.67 Billion | Rs245.74 Billion | Rs181.23 Billion | Rs81.56 Billion | ▼ -1.2 pp |
| 2021 | 41.8% | Rs91.58 Billion | Rs219.29 Billion | Rs198.24 Billion | Rs106.65 Billion | ▲ +11.9 pp |
| 2020 | 29.9% | Rs50.28 Billion | Rs168.25 Billion | Rs164.13 Billion | Rs113.85 Billion | ▲ +5.8 pp |
| 2019 | 24.1% | Rs33.44 Billion | Rs138.92 Billion | Rs153.65 Billion | Rs120.21 Billion | ▼ -6.0 pp |
| 2018 | 30.1% | Rs35.12 Billion | Rs116.82 Billion | Rs121.78 Billion | Rs86.66 Billion | ▲ +2.3 pp |
| 2017 | 27.7% | Rs26.01 Billion | Rs93.74 Billion | Rs92.06 Billion | Rs66.06 Billion | ▼ -8.3 pp |
| 2016 | 36.0% | Rs24.54 Billion | Rs68.18 Billion | Rs102.94 Billion | Rs78.40 Billion | ▼ -5.7 pp |
| 2015 | 41.7% | Rs21.62 Billion | Rs51.82 Billion | Rs82.99 Billion | Rs61.36 Billion | ▲ +4.4 pp |
| 2014 | 37.4% | Rs14.11 Billion | Rs37.76 Billion | Rs56.31 Billion | Rs42.20 Billion | ▲ +10.4 pp |
| 2013 | 26.9% | Rs7.06 Billion | Rs26.22 Billion | Rs41.37 Billion | Rs34.31 Billion | ▲ +12.1 pp |
| 2012 | 14.9% | Rs3.49 Billion | Rs23.50 Billion | Rs32.64 Billion | Rs29.15 Billion | ▼ -7.7 pp |
| 2011 | 22.6% | Rs5.53 Billion | Rs24.49 Billion | Rs33.21 Billion | Rs27.68 Billion | ▼ -75.5 pp |
| 2010 | 98.1% | Rs17.98 Billion | Rs18.33 Billion | Rs25.06 Billion | Rs7.08 Billion | ▼ -40.1 pp |
| 2009 | 138.1% | Rs17.19 Billion | Rs12.44 Billion | Rs22.89 Billion | Rs5.70 Billion | ▲ +7.5 pp |
| 2008 | 130.6% | Rs14.72 Billion | Rs11.27 Billion | Rs20.59 Billion | Rs5.87 Billion | ▼ -56.5 pp |
| 2007 | 187.1% | Rs16.64 Billion | Rs8.90 Billion | Rs21.35 Billion | Rs4.71 Billion | ▲ +61.2 pp |
| 2006 | 125.9% | Rs10.29 Billion | Rs8.17 Billion | Rs14.56 Billion | Rs4.27 Billion | ▲ +28.1 pp |
| 2005 | 97.8% | Rs6.99 Billion | Rs7.14 Billion | Rs10.19 Billion | Rs3.20 Billion | ▲ +2.2 pp |
| 2004 | 95.6% | Rs6.93 Billion | Rs7.25 Billion | Rs9.59 Billion | Rs2.66 Billion | — |